Robbert Michael Hoekstra

Robbert Michael Hoekstra has a diverse work experience spanning various roles in finance, accounting, and management. Robbert Michael is currently serving as the Head of Group Finance at BRAIN Biotech AG since April 2022. Robbert Michael also holds the position of Managing Director for WeissBioTech GmbH, a subsidiary of BRAIN Group. Prior to this, they worked as the Head of Accounting at BRAIN Biotech AG from March 2021 to April 2022.

Before joining BRAIN Biotech AG, Robbert was briefly employed as the Back in Germany role at In between jobs from September 2020 to February 2021. Their previous role was as a Corporate Controller at FDI, where they worked from September 2018 to August 2020.

Robbert has also held positions at VSL Dutch Metrology Institute, where they served as the Statutory/Managing Director from June 2019 to January 2020. Robbert Michael was associated with AB Enzymes as the Group Finance Manager from January 2016 to February 2018. Prior to that, they worked as a Financial Controller at SHV business unit Dyas.

Robbert started their career at Ernst & Young and worked in various roles including Manager at Transaction Advisory Services, Senior Executive at TAS London Office, and Auditor in International Practice. Robbert Michael was associated with Ernst & Young from 2001 to 2013.

Robbert Michael Hoekstra attended St. Stanislas College from 1990 to 1996, where they studied at the Gymnasium level. Robbert Michael then went on to receive their Master's Degree in Financial Management from Erasmus University Rotterdam, graduating in 2001. Following that, they pursued a Post Master degree in Financial Assurance and Accounting at the Rotterdam School of Management, Erasmus University from 2001 to 2008.